Rising Indirect Costs Threaten Research

From Yale To Stanford, Universities Are Thoubled Shortfalls in overhead, depreciation, and other indirect costs can tear apart faculties and bring strong provosts to their knees. Indirect costs aren’t glamorous. They won’t solve the mystery of dinosaur extinction or find the charm in quarks. But whisper those two simple words in the ear of virtually any president or provost of a major research university, and you may see a strong person blanch. The reason: Indirect costs are risin

Written byRay Spangenbueg
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

From Yale To Stanford, Universities Are Thoubled Shortfalls in overhead, depreciation, and other indirect costs can tear apart faculties and bring strong provosts to their knees.

Indirect costs aren’t glamorous. They won’t solve the mystery of dinosaur extinction or find the charm in quarks. But whisper those two simple words in the ear of virtually any president or provost of a major research university, and you may see a strong person blanch. The reason: Indirect costs are rising, contributing to an existing shortfall of cash that threatens the very foundations of research.

No one at a university "especially not scientists toiling in their labs, can escape these costs, which cover everything from maintenance and operations to depreciation and administration. The issue of who pays has torn apart researchers and their university administrators. It has led to strife among faculties, pitting scientists who cover their share against those who do not. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies